Most Shared

Health Matters

Health Matters

 
text size

New hepatitis C drug - worth $1,000 a pill?

Updated: Tuesday, March 11 2014, 11:32 AM EDT

Washington (AP) - An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care experts, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences.

A panel of California medical experts voted Monday that Gilead's Sovaldi represents a "low value" treatment when compared with older drugs for the blood borne virus. The vote was part of a broader review of new hepatitis C drugs by the California Technology Assessment Forum. The insurer-affiliated group assesses the costs and effectiveness of new medical treatments.

The group estimates that replacing currently used hepatitis C drugs with Gilead's Sovaldi would raise California drug costs between $18 billion and $29 billion per year. The drug costs $84,000 for one 12-week course of treatment.

Copyright 2014 The Associated Press. All rights reserved

New hepatitis C drug - worth $1,000 a pill?


Advertise with us!

Related Stories

Health Matters

  [ - ] Video Stories Only  [ - ] Text Stories Only  [ + ] Show All

ABC National Health News

 

Navigation

Elmwood Dental Group, P.C. - Health Watch - WEAR ABC Channel 3
Anthony L. Jordan Health Center - Health Watch - WEAR ABC Channel 3
Hart Hearing Centers - Health Watch - WEAR ABC Channel 3
Orthopaedic Associates of Rochester - Health Watch - WEAR ABC Channel 3
Tender Loving Family Care, Inc. - Health Watch - WEAR ABC Channel 3
Lakeview Eye Care/Better View Optical - Health Watch - WEAR ABC Channel 3
University Medical Imaging - Health Watch - WEAR ABC Channel 3
Advertise with us!